Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 24

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 24
---
-2043* |
| Treatment Of Zika Virus Infections Using Alpha Glucosidase Inhibitors                                                      |     | 10328061+  |     | US      |     |         |     | 6-25-2019      |     |                  15/584,952+ |     | 2-May-2037   |
| Treatment Of Zika Virus Infections Using Alpha Glucosidase Inhibitors                                                      |     | 10561642+  |     | US      |     |         |     | 2-18-2020      |     |                  15/856,377+ |     | 2-May-2037   |

| * = | For foreign patents and                                                                                                             
 applications, the estimated and/or anticipated patent expiration is the date that is twenty years from the PCT filing date. For all 
 issued Australian patents, this estimated date was also confirmed through the Australian patent office web database.                |

| ^ = | For issued U.S. patents, the estimated patent expiration was calculated                                                                         
 using information from the front cover of the patent, i.e., 20 years from the date of the nonprovisional filing plus any listed                 
 Patent Term Adjustment less any time disclaimed through a Terminal Disclaimer. For pending U.S. applications, the anticipated patent expiration 
 is the date twenty years from the earliest nonprovisional filing date and does not account for possible Patent Term Adjustment (PTA),           
 Patent Term Extension (PTE), or Terminal Disclaimers.                                                                                           |

| + = | 60 Degrees Pharmaceuticals, Inc. is not a listed Applicant and Geoffrey 
 S. Dow, Ph.D. is not a listed inventor.                                 |

| 

# = | 60 Degrees Pharmaceuticals, Inc. is not a listed Applicant, but Geoffrey 
 S. Dow, Ph.D. is a listed inventor.                                      |

All patents not designated with a “+” list Geoffrey S. Dow, Ph.D. as an inventor. All patents not designated with a “+” or a “#” list 60 Degrees Pharmaceuticals, Inc. as an applicant. All estimated patent expiration dates and anticipated patent expiration assume payment of any maintenance/annuity fees during the patent term.

12

Trademarks

| Country                   |     | Mark                   |     | Status     |     |  Application 
       Number |     | Date Filed |     | Registration 
 Date         |     | Registration Number |     | BIR Ref Number |     | Due